MediciNova, Inc.
Treatment of progressive neurodegenerative disease with ibudilast
Last updated:
Abstract:
Compositions and methods for treating progressive neurodegenerative diseases, and their associated symptoms by administration of ibudilast (3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine).
Status:
Grant
Type:
Utility
Filling date:
1 May 2019
Issue date:
10 Aug 2021